These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20929331)

  • 1. Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination.
    Pilorge S; Park S; Dreyfus F; Bouscary D; Tamburini J
    Leuk Lymphoma; 2010 Dec; 51(12):2288-90. PubMed ID: 20929331
    [No Abstract]   [Full Text] [Related]  

  • 2. Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia.
    Lazarevic VLj; Liljeholm M; Forsberg K; Söderberg S; Wahlin A
    Leuk Lymphoma; 2008 Jun; 49(6):1209-11. PubMed ID: 18452089
    [No Abstract]   [Full Text] [Related]  

  • 3. Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease.
    Tedeschi A; Benevolo G; Varettoni M; Battista ML; Zinzani PL; Visco C; Meneghini V; Pioltelli P; Sacchi S; Ricci F; Nichelatti M; Zaja F; Lazzarino M; Vitolo U; Morra E
    Cancer; 2012 Jan; 118(2):434-43. PubMed ID: 21732338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the International Scoring System and response in patients with advanced Waldenstrom macroglobulinemia.
    Hivert B; Tamburini J; Vekhoff A; Tournilhac O; Leblond V; Morel P
    Haematologica; 2011 May; 96(5):785-8. PubMed ID: 21393333
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab-induced coagulopathy.
    Novak J; Mocikova H; Pavlicek P; Gaherova L; Kozak T
    Leuk Lymphoma; 2012 Nov; 53(11):2299-301. PubMed ID: 22480246
    [No Abstract]   [Full Text] [Related]  

  • 6. Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemia.
    Tedeschi A; Ricci F; Goldaniga MC; Benevolo G; Varettoni M; Motta M; Pioltelli P; Gini G; Barate' C; Luraschi A; Vismara E; Frustaci AM; Nichelatti M; Vitolo U; Baldini L; Morra E
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):231-4. PubMed ID: 23490992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waldenström macroglobulinemia: my way.
    Gertz M
    Leuk Lymphoma; 2013 Mar; 54(3):464-71. PubMed ID: 22860921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab].
    Tsukasaki K
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():632-5. PubMed ID: 25831837
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab-based treatments in Waldenström's macroglobulinemia.
    Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.
    Gavriatopoulou M; Kastritis E; Kyrtsonis MC; Vassilakopoulos TP; Roussou M; Fotiou D; Migkou M; Mpakiri M; Tasidou A; Terpos E; Dimopoulos MA
    Leuk Lymphoma; 2017 Jun; 58(6):1506-1508. PubMed ID: 27724158
    [No Abstract]   [Full Text] [Related]  

  • 11. Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
    Herold T; Seiler T; Egensperger R; Trumm C; Bergmann M; Franke D; Mumm FF; Schinwald N; Buske C; Dreyling M
    Leuk Lymphoma; 2012 Jan; 53(1):169-72. PubMed ID: 21812535
    [No Abstract]   [Full Text] [Related]  

  • 12. Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
    Marchand T; Revest M; Tattevin P; Chevrier S; Poullot E; Lamy T; Houot R
    Leuk Lymphoma; 2013 Mar; 54(3):643-5. PubMed ID: 22924391
    [No Abstract]   [Full Text] [Related]  

  • 13. Fludarabine-based combination therapies for Waldenström's macroglobulinemia.
    Tedeschi A; Alamos SM; Ricci F; Greco A; Morra E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):67-70. PubMed ID: 19362977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström's macroglobulinemia.
    Herth I; Hensel M; Rieger M; Horstmann K; Hiddemann W; Dreyling M; Koniczek S; Witzens-Harig M; Ho AD
    Leuk Lymphoma; 2015 Jan; 56(1):97-102. PubMed ID: 24724778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine combination therapy is highly effective in first-line and salvage treatment of patients with Waldenström's macroglobulinemia.
    Tam CS; Wolf MM; Westerman D; Januszewicz EH; Prince HM; Seymour JF
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):136-9. PubMed ID: 16231852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).
    Tomás JF; Montalbán C; De Sevilla AF; Martínez-López J; Díaz N; Canales M; Martínez R; Sánchez-Godoy P; Caballero MD; Peñalver J; Prieto E; Salar A; Burgaleta C; Queizán JA; Bajo R; De Oña R; De La Serna J
    Leuk Lymphoma; 2011 Mar; 52(3):409-16. PubMed ID: 21275633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waldenström macroglobulinemia of the orbit.
    Ranchod TM; Mansour TN; Fogt F; Gausas RE
    Ophthalmic Plast Reconstr Surg; 2008; 24(1):76-7. PubMed ID: 18209658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire?
    Zinzani PL; Tani M; Alinari L; Stefoni V; Baccarani M
    Leuk Res; 2003 May; 27(5):465-6. PubMed ID: 12620298
    [No Abstract]   [Full Text] [Related]  

  • 20. Fludarabine, cyclophosphamide, and rituximab chemotherapy followed by rituximab maintenance in follicular lymphoma: high efficacy may come at a cost?
    Tam CS; Seymour JF
    Leuk Lymphoma; 2011 May; 52(5):729-31. PubMed ID: 21504295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.